Urinary ochratoxin A and ochratoxin alpha in pregnant women

Food and Chemical Toxicology

Volumn 50, Issue 12, 2012, Pages 4487-4492

  Klapec, T ^a   Sarkanj B ^a   Banjari, I ^a   Strelec, I ^a  

^a JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

Author keywords

Ochratoxin A; Ochratoxin alpha; Pregnancy; Urine

Indexed keywords

ARYLSULFATASE; BETA GLUCURONIDASE; OCHRATOXIN; OCHRATOXIN ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY WEIGHT; CACAO; CEREAL; COFFEE; CONTROLLED STUDY; CROATIA; DIETARY INTAKE; FEMALE; FRUIT JUICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; LIQUID LIQUID EXTRACTION; MAXIMUM ALLOWABLE CONCENTRATION; METABOLISM; NORMAL HUMAN; PREGNANT WOMAN; QUESTIONNAIRE; THIRD TRIMESTER PREGNANCY; UPREGULATION; URINE LEVEL;

ADULT; ANIMALS; BEVERAGES; CACAO; CEREALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COFFEE; CREATININE; DIET; FEMALE; FOOD CONTAMINATION; FOOD HANDLING; FOOD MICROBIOLOGY; FRUIT; HUMANS; MEAT PRODUCTS; OCHRATOXINS; PREGNANCY; QUESTIONNAIRES; SWINE; VITIS; WINE;

EID: 84868251898     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.09.030     Document Type: Article

References (38)

1. Akdemir C., Cemiloglu Ulker O., Basaran A., Ozkaya S., Karakaya A. Estimation of ochratoxin A in some Turkish populations: an analysis in urine as a simple, sensitive and reliable biomarker. Food Chem. Toxicol. 2010, 48:877-882.
2. Anderson G.D. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin. Pharmacokinet. 2005, 44:989-1008.
3. Cao J., Stieger B., Meier P.J., Vore M. Expression of rat hepatic multidrug resistance associated proteins and organic anion transporters in pregnancy. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283:G757-G766.
4. Cha S.H., Sekine T., Kusushura H., Yu E., Kim J.Y., Kim D.K., Sugiyama Y., Kanai Y., Endou H. Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J. Biol. Chem. 2000, 275:4507-4512.
5. Coronel M.B., Marin S., Tarragó M., Cano-Sancho G., Ramos A.J., Sanchos V. Ochratoxin A and its metabolite ochratoxin alpha in urine and assessment of the exposure of inhabitants of Lleida, Spain. Food Chem. Toxicol. 2011, 49:1436-1442.
6. Domijan A-M., Peraica M., Markov K., Fuchs R. Urine ochratoxin A and sphinganine/sphingosine ratio in residents of the endemic nephropathy area in Croatia. Arh. Hig. Rada Toksikol. 2009, 60:387-393.
7. Duarte S.C., Alves M.R., Pena A., Lino C.M. Determinants of ochratoxin A exposure - A one year follow-up study of urine levels. Int. J. Hyg. Environ. Health 2012, 215:360-367.
8. Duarte S.C., Lino C.M., Pena A. Food safety implications of ochratoxin A in animal-derived food products. Vet. J. 2012, 192:286-292.
9. EFSA, European Food Safety Authority Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the commission related to ochratoxin A in food. EFSA J. 2006, 356:1-56.
10. FAO/WHO, Food and Agriculture Organization of the United Nations and World Health Organization, 2001. Ochratoxin A, in: Evaluation of Certain Mycotoxins in Food, Fifty sixth Report of the Joint FAO/WHO Expert Committee on Food Additives, WHO Technical Report Series 906. WHO, Geneva, pp. 27-35.
11. FAO/WHO, Food and Agriculture Organization of the United Nations and World Health Organization, 2008. Ochratoxin A (addendum), in: Safety Evaluation of Certain Food Additives and Contaminants. Prepared by the sixty-eighth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series 59. WHO, Geneva, pp. 357-429.
12. Fazekas B., Tar A., Kovács M. Ochratoxin A content of urine samples of healthy humans in Hungary. Acta Vet. Hung. 2005, 53:35-44.
13. Gilbert J., Brereton P., MacDonald S. Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit. Contam. 2001, 18:1088-1093.
14. Gross-Steinmeyer K., Weymann J., Hege H.G., Metzler M. Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured and human primary hepatocytes. J. Agric. Food Chem. 2002, 50:935-938.
15. Hebert M.F., Easterling T.R., Kirby B., Carr D.B., Buchanan M.L., Rutherford T., Thummel K.E., Fishbein D.P., Unadkat J.D. Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin. Pharmacol. Ther. 2008, 84:248-253.
16. Inoue H., Tsuruta A., Kudo S., Ishii T., Fukushima Y., Iwano H., Yokota H., Kato S. Bisphenol A glucuronidation and excretion in liver of pregnant and nonpregnant female rats. Drug Metab. Dispos. 2004, 33:55-59.
17. Klapec, T., 2001. The role of dietary selenium intake in the etiology of endemic nephropathy [In Croatian]. Ph.D. thesis. Faculty of Food Technology, Osijek.
18. Koren O., Goodrich J.K., Cullender T.C., Spor A., Laitinen K., Bäckhed H.K., Gonzalez A., Werner J.J., Angenent L.T., Knight R., Bäckhed F., Isolauri E., Salminen S., Ley R.E. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012, 150:470-480.
19. Kushari J., Mukherjea M. Studies on beta-glucuronidase of the developing human placenta. Gynecol. Obstet. Invest. 1980, 11:119-127.
20. Lino C.M., Baeta M.L., Henri M., Dinis A.M.P., Pena A.S., Silveira M.I.N. Levels of ochratoxin A in serum from urban and rural Portuguese populations and estimation of exposure degree. Food Chem. Toxicol. 2008, 46:879-885.
21. Maynard S.E., Thadhani R. Pregnancy and the kidney. J. Am. Soc. Nephrol. 2009, 20:14-22.
22. Miletić-Medved, M, Domijan A-M., Peraica M. Recent data on endemic nephropathy and related urothelial tumors in Croatia. Wien. Klin. Wochenschr. 2005, 117:604-609.
23. Möller T.E., Nyberg M. Ochratoxin A in raisins and currants: basic extraction procedure used in two small marketing surveys of the occurrence and control of the heterogeneity of the toxins in samples. Food Addit. Contam. 2003, 20:1072-1076.
24. Muñoz, K, Blaszkewicz M., Degen H. Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin. J. Chromatogr. B 2010, 878:2623-2629.
25. Öhman I., Luef G., Tomson T. Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites. Seizure 2008, 17:199-202.
26. Pena A., Seifrtová M., Lino C., Silveira I., Solich P. Estimation of ochratoxin A in portuguese population: new data on the occurrence in human urine by high performance liquid chromatography with fluorescence detection. Food Chem. Toxicol. 2006, 44:1449-1454.
27. Pepeljnjak S., Šegvić Klarić M. Suspects in etiology of endemic nephropathy: aristolochic acid versus mycotoxins. Toxins 2010, 2:1414-1427.
28. Peraica M., Domijan A-M., Matašin M., Lucić A., Radić B., Delaš F., Horvat M., Bosanac I., Balija M., Grgičević D. Variations in ochratoxin A in the blood of healthy populations in some Croatian cities. Arch. Toxicol. 2001, 75:410-414.
29. Pfohl-Leszkowicz A. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh. Hig. Rada Toksikol. 2009, 60:465-483.
30. Pfohl-Leszkowicz A., Petkova-Bocharova T., Chernozemsky I.N., Castegnaro M. Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 2002, 19:282-302.
31. Reimers A., Helde G., Brodtkorb E. Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia 2005, 46:1414-1417.
32. Ringot D., Chango A., Schneider Y-J., Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem-Biol. Interact. 2006, 159:18-46.
33. Schwartz G.G. Hypothesis: does ochratoxin A cause testicular cancer?. Cancer Cause Control 2002, 13:91-100.
34. Doorten Simarro, A.Y., Bull, S., Doelen van der, M.A.M., Fink-Gremmels, J. Metabolism-mediated cytotoxicity of ochratoxin A. Toxicol. In Vitro 2004, 18:271-277.
35. Sinčić N., Kuliš T., Znaor A., Bray F. Time trends in testicular cancer in Croatia 1983-2007: rapid increases in incidence, no declines in mortality. Cancer Epidemiol. 2012, 36:11-15.
36. Solfrizzo M., Gambacorta L., Lattanzio V.M.T., Powers S., Visconti A. Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, α and β-zearalenols and fumonisin B1 in urine as a multibiomarker method to assess exposure to mycotoxins. Anal. Bioanal. Chem. 2011, 401:2831-2841.
37. Woodmansey E.J. Intestinal bacteria and ageing. J. Appl. Microbiol. 2007, 102:1178-1186.
38. Zimmerli B., Dick R. Determination of ochratoxin A at ppt level in human blood, serum, milk and some foodstuffs by high performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column clean-up; methodology and Swiss data. J. Chromatogr. B 1995, 666:85-99.